Overview

Effect of Adjunctive Intracoronary Streptokinase on Late Term Left Ventricular Infarct Size and Volumes in Patients With Acute Myocardial Infarction

Status:
Completed

Trial end date:
2008-02-01

Target enrollment:

Participant gender:

Summary

The investigators hypothesized that complementary intracoronary streptokinase administration to primary percutaneous intervention in patients with acute myocardial infarction may provide limitation infarct size and improvement in left ventricular volumes and function in acute and late phases (6 months).

Phase:

Phase 4

Details

Lead Sponsor:

Istanbul University

Treatments:

Streptokinase